93 related articles for article (PubMed ID: 7100263)
1. Bromperidol maintenance in schizophrenia.
McEvoy JP; Wilson WH; Ban TA; Brannen JO; Berney S
Pharmacopsychiatria; 1982 May; 15(3):95-6. PubMed ID: 7100263
[TBL] [Abstract][Full Text] [Related]
2. A double-blind comparison of bromperidol and haloperidol in newly admitted schizophrenic patients.
Brannen JO; McEvoy JP; Wilson WH; Petrie WM; Ban TA; Berney SA; Schaffer JD
Pharmacopsychiatria; 1981 Jul; 14(4):139-40. PubMed ID: 6116246
[No Abstract] [Full Text] [Related]
3. Effects and side-effects of bromperidol in comparison with other antipsychotic drugs.
Woggon B
Acta Psychiatr Belg; 1978; 78(1):155-72. PubMed ID: 347878
[TBL] [Abstract][Full Text] [Related]
4. Results of a clinical trial with bromperidol C-C 2489/21.
Weiser G
Acta Psychiatr Belg; 1978; 78(1):102-9. PubMed ID: 347873
[TBL] [Abstract][Full Text] [Related]
5. The initial US clinical experience in the management of schizophrenic patients with bromperidol.
Gardner E
Acta Psychiatr Belg; 1978; 78(1):134-46. PubMed ID: 347876
[TBL] [Abstract][Full Text] [Related]
6. [Treatment with bromperidol in schizophrenic patients].
Ellerman LA
Acta Psiquiatr Psicol Am Lat; 1989; 35(1-2):23-30. PubMed ID: 2634329
[TBL] [Abstract][Full Text] [Related]
7. Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates.
McLaren S; Cookson JC; Silverstone T
Int Clin Psychopharmacol; 1992 Nov; 7(2):67-72. PubMed ID: 1487623
[TBL] [Abstract][Full Text] [Related]
8. Double-blind- evaluation of bromperidol versus haloperidol treatment in chronic psychotic patients.
Malfroid M; Hens L; Roosen P; Dom R
Acta Psychiatr Belg; 1978; 78(1):147-54. PubMed ID: 347877
[TBL] [Abstract][Full Text] [Related]
9. Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo.
Eklund K; Forsman A
Clin Neuropharmacol; 1991; 14 Suppl 2():S7-12; discussion S12-5. PubMed ID: 1684310
[TBL] [Abstract][Full Text] [Related]
10. A single-blind comparison of bromperidol and sulpiride in hospitalized schizophrenics.
Yamagami S; Hirayama E; Mui K; Okuno M; Kioka T; Soma T; Ohno K
Acta Psychiatr Belg; 1993; 93(4):236-44. PubMed ID: 7913572
[TBL] [Abstract][Full Text] [Related]
11. [Treatment with bromperidol in schizophrenic patients].
Ellerman LA
Acta Psiquiatr Psicol Am Lat; 1988 Dec; 34(4):335-40. PubMed ID: 2908218
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Chouinard G; Annable L; Campbell W
J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
[TBL] [Abstract][Full Text] [Related]
13. Amisulpride versus haloperidol in treatment of schizophrenic patients--results of a double-blind study.
Delcker A; Schoon ML; Oczkowski B; Gaertner HJ
Pharmacopsychiatry; 1990 May; 23(3):125-30. PubMed ID: 1973843
[TBL] [Abstract][Full Text] [Related]
14. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():36-40. PubMed ID: 1683338
[TBL] [Abstract][Full Text] [Related]
15. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
Abuzzahab FS; Zimmerman RL
J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
Cesková E; Svestka J
Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
[TBL] [Abstract][Full Text] [Related]
17. Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.
Suzuki E; Kanba S; Koshikawa H; Nibuya M; Yagi G; Asai M
J Psychiatry Neurosci; 1996 May; 21(3):167-71. PubMed ID: 8935328
[TBL] [Abstract][Full Text] [Related]
18. Clinical experiences in an open and a double-blind trial.
Pöldinger W
Acta Psychiatr Belg; 1978; 78(1):96-101. PubMed ID: 347884
[TBL] [Abstract][Full Text] [Related]
19. [Bromperidol decanoate in the residual phase of schizophrenia].
Smeraldi E; Cocconcelli C; Canova L; Faravelli C; Marchetti FP; Mariani G; Rapisarda V
Minerva Psichiatr; 1996 Mar; 37(1):39-44. PubMed ID: 8926856
[TBL] [Abstract][Full Text] [Related]
20. [Double-blind comparison of 3 x 75 mg zotepine und 3 x 4 mg haloperidol in acute schizophrenic patients].
Klieser E; Lehmann E; Tegeler J
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():14-7. PubMed ID: 1683333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
